The forecast for out-of-pocket health expenditure in Brazil shows a steady decline from 2024 to 2028. In 2023, this expenditure stood at 25.18% of the total current health expenditure. The year-on-year variations indicate a consistent decrease: 2024 by 1.43%, 2025 by 1.45%, 2026 by 1.43%, 2027 by 1.45%, and 2028 by 1.43%. Over the last two years, the variations have shown a decreasing trend, and the Compound Annual Growth Rate (CAGR) over the last five years is -1.45%, reflecting a slow but steady reduction in the proportion of out-of-pocket expenses.
Future trends to watch for:
- *Healthcare policies and reforms aimed at reducing out-of-pocket expenses*
- *Public and private healthcare investments improving infrastructure and insurance coverage*
- *Economic factors and their impact on healthcare affordability*
- *Innovations in healthcare delivery and their efficiency in cost management*
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...